Saving of U.S. costs through generic cardiovascular pharmaceuticals 2004-2013

This statistic displays the cost savings in the United States associated with using generic cardiovascular pharmaceuticals from 2004 to 2013. In 2004, over 18.1 billion U.S. dollars were saved due to generic medication in the cardiovascular therapy area. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals.

Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

October 2014

Region

United States

Survey time period

2004 to 2013

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Generics and biosimilars in Italy"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.